Higher expression of METTL1 and its cofactor WDR4 were significantly associated with poorer overall survival in LGG and LIHC, indicating an oncogenic role of the METTL1/WDR4 methyltransferase in these cancers (Figure 2A). This evidence concerns the gene WDR4 and cancer.